Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 15 July 2013 | By Louise Zornoza,
Brazil's National Agency for Sanitary Surveillance (Anvisa) opened a public consultation (Consultation No. 22/13) on 12 July 2013 concerning new requirements for reporting manufacturing changes for active pharmaceutical ingredients (APIs).
The proposal provides a classification system as to the types of possible changes and the reporting procedures that should be adopted in each case. The manufacturer would have to notify Anvisa of changes according to the impact on the safety of the product. For certain changes, the notification must be made annually, while others require immediate notification to the agency after the changes have been implemented or even before their adoption.
The deadline for comments is 2 September 2013.
Anvisa Consultation
Read all Breaking News from RegLink
Tags: Consultation, pharmaceutical, brazil, drug, API
Regulatory Focus newsletters
All the biggest regulatory news and happenings.